Paper29242563
CK2 modulates adipocyte insulin-signaling and is up-regulated in human obesity.
Borgo C and 14 others. Sci Rep, 2017. Cited by 31 papers, by iCite.
Cite this record
ConductScience Library. CK2 modulates adipocyte insulin-signaling and is up-regulated in human obesity. Papers, record 29242563. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29242563
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adipocytes | Major topic |
| Casein Kinase II | Major topic |
| Insulin | Major topic |
| Obesity | Major topic |
| Signal Transduction | Major topic |
| Up-Regulation | Major topic |
| 3T3-L1 Cells | |
| Adipose Tissue, White | |
| Animals | |
| Biological Transport | |
| Glucose | |
| Humans | |
| Liver | |
| Mice | |
| Muscle, Skeletal |
Source PubMed
References47
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24769357 | Differential phosphorylation of Akt1 and Akt2 by protein kinase CK2 may account for isoform specific functions. | Biochim Biophys Acta | 2014 | https://conductscience.org/library/papers/24769357 | PubMed |
| 2 | 16493415 | Critical nodes in signalling pathways: insights into insulin action. | Nat Rev Mol Cell Biol | 2006 | https://conductscience.org/library/papers/16493415 | PubMed |
| 3 | 27001465 | CK2 inhibition induced PDK4-AMPK axis regulates metabolic adaptation and survival responses in glioma. | Exp Cell Res | 2016 | https://conductscience.org/library/papers/27001465 | PubMed |
| 4 | 22917893 | CK2 and the regulation of the carbohydrate metabolism. | Metabolism | 2012 | https://conductscience.org/library/papers/22917893 | PubMed |
| 5 | 12527361 | Glucosamine-induced insulin resistance is coupled to O-linked glycosylation of Munc18c. | FEBS Lett | 2003 | https://conductscience.org/library/papers/12527361 | PubMed |
| 6 | 24113830 | Metabolic targets for cancer therapy. | Nat Rev Drug Discov | 2013 | https://conductscience.org/library/papers/24113830 | PubMed |
| 7 | 21633177 | Adipose tissue remodeling and obesity. | J Clin Invest | 2011 | https://conductscience.org/library/papers/21633177 | PubMed |
| 8 | 27256476 | Targeting adipose tissue in the treatment of obesity-associated diabetes. | Nat Rev Drug Discov | 2016 | https://conductscience.org/library/papers/27256476 | PubMed |
| 9 | 17195063 | Pten (phosphatase and tensin homologue gene) haploinsufficiency promotes insulin hypersensitivity. | Diabetologia | 2007 | https://conductscience.org/library/papers/17195063 | PubMed |
| 10 | 15358133 | 2-Dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole: a novel powerful and selective inhibitor of protein kinase CK2. | Biochem Biophys Res Commun | 2004 | https://conductscience.org/library/papers/15358133 | PubMed |
| 11 | 11035045 | The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation. | J Biol Chem | 2001 | https://conductscience.org/library/papers/11035045 | PubMed |
| 12 | 19665589 | Addiction to protein kinase CK2: a common denominator of diverse cancer cells? | Biochim Biophys Acta | 2010 | https://conductscience.org/library/papers/19665589 | PubMed |
| 13 | 15166380 | A family with severe insulin resistance and diabetes due to a mutation in AKT2. | Science | 2004 | https://conductscience.org/library/papers/15166380 | PubMed |
| 14 | 1849075 | Identification of the regulatory phosphorylation sites in pp42/mitogen-activated protein kinase (MAP kinase). | EMBO J | 1991 | https://conductscience.org/library/papers/1849075 | PubMed |
| 15 | 3321056 | Activation of casein kinase II in response to insulin and to epidermal growth factor. | Proc Natl Acad Sci U S A | 1987 | https://conductscience.org/library/papers/3321056 | PubMed |
| 16 | 19662498 | Dephosphorylation and inactivation of Akt/PKB is counteracted by protein kinase CK2 in HEK 293T cells. | Cell Mol Life Sci | 2009 | https://conductscience.org/library/papers/19662498 | PubMed |
| 17 | 26598688 | CK2 acts as a potent negative regulator of receptor-mediated insulin release in vitro and in vivo. | Proc Natl Acad Sci U S A | 2015 | https://conductscience.org/library/papers/26598688 | PubMed |
| 18 | 19755644 | Obesity and cancer: the role of dysfunctional adipose tissue. | Cancer Epidemiol Biomarkers Prev | 2009 | https://conductscience.org/library/papers/19755644 | PubMed |
| 19 | 22970944 | PTEN mutations as a cause of constitutive insulin sensitivity and obesity. | N Engl J Med | 2012 | https://conductscience.org/library/papers/22970944 | PubMed |
| 20 | 24012109 | Aberrant signalling by protein kinase CK2 in imatinib-resistant chronic myeloid leukaemia cells: biochemical evidence and therapeutic perspectives. | Mol Oncol | 2013 | https://conductscience.org/library/papers/24012109 | PubMed |
Cited by24
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 31 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42907441 | Microglial protein kinase CK2 prevents obesity in mice potentially through NLRP3 inflammasome activation. | Nat Commun | 2026 | https://conductscience.org/library/papers/42907441 | PubMed |
| 41922796 | Antipsychotic-like effects of the selective Rho-kinase 2 inhibitor KD025 in genetic and pharmacological mouse models of schizophrenia. | Mol Psychiatry | 2026 | https://conductscience.org/library/papers/41922796 | PubMed |
| 41441338 | Comprehensive Insights into Obesity and Type 2 Diabetes from Protein Network, Canonical Pathway, Phosphorylation and Antimicrobial Peptide Signatures of Human Serum. | Proteomes | 2025 | https://conductscience.org/library/papers/41441338 | PubMed |
| 40927979 | Pharmacological inhibition of casein kinase II attenuates metaflammation in a murine model of diet‑induced metabolic dysfunction. | Int J Mol Med | 2025 | https://conductscience.org/library/papers/40927979 | PubMed |
| 39726006 | Protein kinase CK2 sustains de novo fatty acid synthesis by regulating the expression of SCD-1 in human renal cancer cells. | Cancer Cell Int | 2024 | https://conductscience.org/library/papers/39726006 | PubMed |
| 39559755 | MOTS-c modulates skeletal muscle function by directly binding and activating CK2. | iScience | 2024 | https://conductscience.org/library/papers/39559755 | PubMed |
| 39433024 | European Association for the Study of Obesity (EASO) Position Statement on Medical Nutrition Therapy for the Management of Individuals with Overweight or Obesity and Cancer. | Obes Facts | 2025 | https://conductscience.org/library/papers/39433024 | PubMed |
| 39280566 | Can Bone Morphogenetic Protein 1 (BMP1) Be a Potential Biomarker of Obesity? | Cureus | 2024 | https://conductscience.org/library/papers/39280566 | PubMed |
| 38132153 | Protein Kinase CK2α', More than a Backup of CK2α. | Cells | 2023 | https://conductscience.org/library/papers/38132153 | PubMed |
| 37966572 | Unraveling the rationale and conducting a comprehensive assessment of KD025 (Belumosudil) as a candidate drug for inhibiting adipogenic differentiation-a systematic review. | Naunyn Schmiedebergs Arch Pharmacol | 2024 | https://conductscience.org/library/papers/37966572 | PubMed |
| 37238992 | Obesity, the Adipose Organ and Cancer in Humans: Association or Causation? | Biomedicines | 2023 | https://conductscience.org/library/papers/37238992 | PubMed |
| 36756374 | Hyperphosphorylation of hepatic proteome characterizes nonalcoholic fatty liver disease in S-adenosylmethionine deficiency. | iScience | 2023 | https://conductscience.org/library/papers/36756374 | PubMed |
| 34716543 | Adipogenic progenitors in different organs: Pathophysiological implications. | Rev Endocr Metab Disord | 2022 | https://conductscience.org/library/papers/34716543 | PubMed |
| 34443331 | ROCK2-Specific Inhibitor KD025 Suppresses Adipocyte Differentiation by Inhibiting Casein Kinase 2. | Molecules | 2021 | https://conductscience.org/library/papers/34443331 | PubMed |
| 33994545 | Protein kinase CK2: a potential therapeutic target for diverse human diseases. | Signal Transduct Target Ther | 2021 | https://conductscience.org/library/papers/33994545 | PubMed |
| 33477590 | Contribution of the CK2 Catalytic Isoforms α and α' to the Glycolytic Phenotype of Tumor Cells. | Cells | 2021 | https://conductscience.org/library/papers/33477590 | PubMed |
| 33114687 | White Adipose Tissue Expansion in Multiple Symmetric Lipomatosis Is Associated with Upregulation of CK2, AKT and ERK1/2. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/33114687 | PubMed |
| 33052585 | Role of CK2 inhibitor CX-4945 in anti-cancer combination therapy - potential clinical relevance. | Cell Oncol (Dordr) | 2020 | https://conductscience.org/library/papers/33052585 | PubMed |
| 33027921 | Role of Protein Kinase CK2 in Aberrant Lipid Metabolism in Cancer. | Pharmaceuticals (Basel) | 2020 | https://conductscience.org/library/papers/33027921 | PubMed |
| 31500224 | Protein Kinase CK2-A Putative Target for the Therapy of Diabetes Mellitus? | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31500224 | PubMed |
Genes23
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29242563
GET https://conductscience.org/api/papers/v1/29242563/references?page=2